Ohm Fatigue Relief

Aceticum Ac, Adrenal Gland, Arnica, Benzoicum Ac, Ferrum Phos, Fluoricum Ac, Ginseng, Kali Carb, Kali Lod, Kali Mur, Kali Phos, Lacticum Ac, Phosphoricum Ac, Picricum Ac.

Ohm Pharma Inc.
Human Otc Drug
NDC 66096-120

Ohm Fatigue Relief also known as Aceticum Ac, Adrenal Gland, Arnica, Benzoicum Ac, Ferrum Phos, Fluoricum Ac, Ginseng, Kali Carb, Kali Lod, Kali Mur, Kali Phos, Lacticum Ac, Phosphoricum Ac, Picricum Ac. is a human otc drug labeled by 'Ohm Pharma Inc.'. National Drug Code (NDC) number for Ohm Fatigue Relief is 66096-120. This drug is available in dosage form of Liquid. The names of the active, medicinal ingredients in Ohm Fatigue Relief drug includes Acetic Acid - 30 [hp_X]/59mL Arnica Montana - 12 [hp_X]/59mL Asian Ginseng - 3 [hp_X]/59mL Benzoic Acid - 30 [hp_X]/59mL Bos Taurus Adrenal Gland - 10 [hp_X]/59mL Dibasic Potassium Phosphate - 3 [hp_X]/59mL Ferrosoferric Phosphate - 6 [hp_X]/59mL Hydrofluoric Acid - 30 [hp_X]/59mL Lactic Acid, Dl- - 30 [hp_X]/59mL Phosphoric Acid - 30 [hp_X]/59mL and more. The currest status of Ohm Fatigue Relief drug is Active.

Drug Information:

Drug NDC:	66096-120
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name:	Ohm Fatigue Relief
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type:	Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name:	Aceticum Ac, Adrenal Gland, Arnica, Benzoicum Ac, Ferrum Phos, Fluoricum Ac, Ginseng, Kali Carb, Kali Lod, Kali Mur, Kali Phos, Lacticum Ac, Phosphoricum Ac, Picricum Ac.
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name:	Ohm Pharma Inc.
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form:	Liquid
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status:	Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:	ACETIC ACID - 30 [hp_X]/59mL ARNICA MONTANA - 12 [hp_X]/59mL ASIAN GINSENG - 3 [hp_X]/59mL BENZOIC ACID - 30 [hp_X]/59mL BOS TAURUS ADRENAL GLAND - 10 [hp_X]/59mL DIBASIC POTASSIUM PHOSPHATE - 3 [hp_X]/59mL FERROSOFERRIC PHOSPHATE - 6 [hp_X]/59mL HYDROFLUORIC ACID - 30 [hp_X]/59mL LACTIC ACID, DL- - 30 [hp_X]/59mL PHOSPHORIC ACID - 30 [hp_X]/59mL Load more... PICRIC ACID - 30 [hp_X]/59mL POTASSIUM CARBONATE - 4 [hp_X]/59mL POTASSIUM CHLORIDE - 3 [hp_X]/59mL POTASSIUM IODIDE - 3 [hp_X]/59mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:	ORAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Marketing Category:	UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date:	21 May, 2015
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date:	10 Jun, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date:	31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Manufacturer Name:	OHM PHARMA INC.
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:	Yes
Whether or not the drug has been repackaged for distribution.
UPC:	0366096120054
UPC stands for Universal Product Code.
NUI:	N0000175806 N0000175807
Unique identifier applied to a drug concept within the National Drug File Reference Terminology (NDF-RT).
UNII:	Q40Q9N063P O80TY208ZW CUQ3A77YXI 8SKN0B0MIM M2776SWB29 CI71S98N1Z 91GQH8I5F7 RGL5YE86CZ 3B8D35Y7S4 E4GA8884NN Load more... A49OS0F91S BQN1B9B9HA 660YQ98I10 1C4QK22F9J
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.
Pharmacologic Class MOA:	Ammonium Ion Binding Activity [MoA]
Mechanism of action of the drug—molecular, subcellular, or cellular functional activity—of the drug’s established pharmacologic class. Takes the form of the mechanism of action, followed by `[MoA]` (such as `Calcium Channel Antagonists [MoA]` or `Tumor Necrosis Factor Receptor Blocking Activity [MoA]`.
Pharmacologic Class EPC:	Nitrogen Binding Agent [EPC]
Established pharmacologic class associated with an approved indication of an active moiety (generic drug) that the FDA has determined to be scientifically valid and clinically meaningful. Takes the form of the pharmacologic class, followed by `[EPC]` (such as `Thiazide Diuretic [EPC]` or `Tumor Necrosis Factor Blocker [EPC]`.
Pharmacologic Class:	Ammonium Ion Binding Activity [MoA] Increased Large Intestinal Motility [PE] Inhibition Large Intestine Fluid/Electrolyte Absorption [PE] Nitrogen Binding Agent [EPC] Osmotic Activity [MoA] Osmotic Laxative [EPC] Potassium Compounds [CS] Potassium Salt [EPC]
These are the reported pharmacological class categories corresponding to the SubstanceNames listed above.

Packaging Information:

Package NDC	Description	Marketing Start Date	Marketing End Date	Sample Available
66096-120-05	59 mL in 1 BOTTLE, SPRAY (66096-120-05)	21 May, 2015	N/A	No
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Other medicines with the same generic name

Ohm Fatigue Relief

Aceticum Ac & more..

Liquid
OHM PHARMA INC.
NDC: 66096-120

Purpose:

Temporarily relieves general weakness.

Product Elements:

Ohm fatigue relief aceticum ac, adrenal gland, arnica, benzoicum ac, ferrum phos, fluoricum ac, ginseng, kali carb, kali lod, kali mur, kali phos, lacticum ac, phosphoricum ac, picricum ac. alcohol water glycerin acetic acid acetic acid bos taurus adrenal gland bos taurus adrenal gland arnica montana arnica montana benzoic acid benzoic acid ferrosoferric phosphate ferrosoferric phosphate hydrofluoric acid fluoride ion asian ginseng asian ginseng potassium carbonate carbonate ion potassium iodide iodide ion potassium chloride potassium cation dibasic potassium phosphate phosphate ion lactic acid, dl- lactic acid, dl- phosphoric acid phosphoric acid picric acid picric acid

Indications and Usage:

Uses: temporarily relieves general weakness. improves stamina.** â**this statement has not been evaluated by the fda. it is based on documented homeopathic materia medica.

Warnings:

If pregnant or breast-feeding, ask a health professional before use. if symptoms worsen or persist for more than a week, discontinue use and contact a doctor. âkeep out of reach of children.

Dosage and Administration:

Directions: shake 10 times before use. adults & children above 12 years of age: spray 3-4 times under the tongue every 15 minutes, extend intervals as symptoms improve or as directed by a health care professional. children under 12: use half the adult dose.

Package Label Principal Display Panel:

Homeopathic medicine ndc: 66096-120-05 fatigue relief natural - safe - effective no side effects 2 fl oz (59ml) / 15% alcohol product of usa 2oz bottle label temporarily relieves general weakness.

Further Questions:

Mfg. by: ohm pharma, inc. mineral wells, tx 76067 www.ohmpharma.com

Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.